|
|
Volumn 34, Issue 10, 2006, Pages 387-390
|
|
Management of rheumatoid arthritis
|
|
Author keywords
anti TNF drugs; diagnosis; disease modifying anti rheumatic drugs; management; prognosis; remission; rheumatoid arthritis
|
|
Indexed keywords
ADALIMUMAB;
AUROTHIOMALATE;
AZATHIOPRINE;
CYCLOSPORIN;
DISEASE MODIFYING ANTIRHEUMATIC DRUG;
ETANERCEPT;
HYDROXYCHLOROQUINE;
INFLIXIMAB;
LEFLUNOMIDE;
METHOTREXATE;
METHYLPREDNISOLONE;
NONSTEROID ANTIINFLAMMATORY AGENT;
SALAZOSULFAPYRIDINE;
STEROID;
TRIAMCINOLONE ACETONIDE;
ADD ON THERAPY;
ALOPECIA;
CLINICAL EXAMINATION;
COMBINATION CHEMOTHERAPY;
CORNEA DISEASE;
DIARRHEA;
DRUG COST;
DRUG DOSE INCREASE;
DRUG DOSE REDUCTION;
DRUG MEGADOSE;
DRUG RESPONSE;
DRUG TREATMENT FAILURE;
DRUG USE;
EARLY DIAGNOSIS;
HUMAN;
HYPERTENSION;
KIDNEY DISEASE;
LABORATORY TEST;
LIVER FUNCTION TEST;
LOW DRUG DOSE;
LUNG TOXICITY;
MEMBRANOUS GLOMERULONEPHRITIS;
MONOTHERAPY;
MOUTH ULCER;
NAUSEA;
NEUTROPENIA;
OSTEOPOROSIS;
PATIENT EDUCATION;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEINURIA;
RASH;
REMISSION;
RETINOPATHY;
REVIEW;
RHEUMATOID ARTHRITIS;
SIDE EFFECT;
THROMBOCYTOPENIA;
UNITED KINGDOM;
|
|
EID: 33845352176
PISSN: 13573039
EISSN: None
Source Type: Journal
DOI: 10.1053/j.mpmed.2006.07.004 Document Type: Review |
|
Times cited : (4)
|
|
References (8)
|
